Lifecanvas Technologies Inc.

Lifecanvas Technologies Inc. is a Cambridge, Massachusetts-based minority-owned and woman-owned small disadvantaged business that specializes in advanced bioimaging solutions for spatial biology and neuroscience research. The company provides sophisticated equipment, contract research organization services, and data analysis systems that enable high-resolution three-dimensional imaging of biological tissues. Lifecanvas has established itself as a specialized provider to federal research institutions, particularly within the National Institutes of Health and the Department of Veterans Affairs, delivering innovative tissue processing, whole-organ imaging, and analytical platforms that support cutting-edge neuroscience research.

Through federal contract awards, Lifecanvas Technologies has provided a diverse portfolio of bioimaging equipment and contract research services to multiple federal agencies. The company has delivered light sheet microscope systems, including SMARTSPIM and SMARTCLEAR platforms, to the National Institute of Neurological Disorders and Stroke, National Institute of Child Health and Human Development, and National Institute on Alcohol Abuse and Alcoholism. Additionally, Lifecanvas has supplied specialized equipment such as the SMARTBATCH+ high-throughput electrophoretic tissue clearing and immunolabeling device, the Megatome precision vibrating microtome for tissue sectioning, and the SMARTLABEL imaging system. The company has provided contract research organization services encompassing tissue clearing, immunolabeling, light sheet microscopy imaging, and comprehensive data analysis for whole-organ and whole-brain samples across multiple institutes. Funding for these contract awards has come from various NIH components, including the National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and National Institute on Aging, as well as the Department of Veterans Affairs through multiple Veterans Integrated Service Networks. Most contracts have been awarded as purchase orders without set-aside designations, reflecting the specialized and unique nature of Lifecanvas' offerings, though several contracts have been designated as Total Small Business set-asides. The contract values have ranged from approximately $13,000 to $344,950, with cumulative contract awards totaling over $1.2 million since 2021.

Through federal grant awards, Lifecanvas Technologies has received two prime project grants from the National Institute of Mental Health to develop advanced technologies for neuroscience research. The first grant, awarded in February 2021 with completion in January 2023, focused on developing artificial intelligence-driven biomarker analysis tools through a software platform called SMARTANALYTICS, designed to identify labeled cell locations and characterize morphological features across whole brains at cellular and sub-cellular resolution using machine learning algorithms trained on high-volume whole-organ imaging datasets. The second grant, awarded in June 2023 with completion anticipated in May 2025, supports the development of high-throughput three-dimensional mapping technologies for large mammalian brains through integration of precision tissue sectioning and light sheet imaging, including an advanced vibrating microtome for automatic precision slicing of samples as large as intact human brain hemispheres and optimized light sheet microscopy systems. These grants represent Lifecanvas' commitment to pioneering technological innovations in spatial proteomics and whole-organ imaging analysis to address critical gaps in current neuroscience research capabilities.